June 28, 2024 02:24 PM EDT
Pharma
FDA+
Law

Why the Supreme Court's over­rule of Chevron has ma­jor im­pli­ca­tions for the FDA

Lia DeGroot

The Supreme Court on Fri­day over­ruled a long­stand­ing le­gal doc­trine that gives fed­er­al agen­cies lat­i­tude to in­ter­pret fed­er­al law, which le­gal …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Is there room for MASH drugs in a GLP-1 world?

'We play to win': As­traZeneca de­tails first re­sults for oral GLP-1 and broad­er obe­si­ty am­bi­tions

Viking's oral weight loss drug ap­pears to have strong ef­fect in Phase 1 tri­al

BioN­Tech says VEGF bis­pe­cif­ic’s PD-L1 tar­get, com­bo plans will be its edge

No­vo, As­cendis to work on month­ly GLP-1; KalVista makes a roy­al­ty deal

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times